Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Paillard

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Human Gene Therapy|November 14, 1997
Naked DNA gene delivery to the liverF Paillard
Human Gene Therapy|June 13, 1998
Epstein-Barr virus vectors for the treatment of Epstein-Barr virus-associated cancersF Paillard
Human Gene Therapy|April 29, 1998
Simian virus 40 as a vector for gene transfer to hematopoietic cellsF Paillard
Human Gene Therapy|December 31, 1997
Promoter attenuation in gene therapy: causes and remediesF Paillard
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 6, 2003
[Nutritional counseling for coronary and hypertensive patients]F Paillard
Human Gene Therapy|February 4, 1998
Tumor-specific transgene expression: an application for hepatocarcinoma gene therapyF Paillard
Human Gene Therapy|February 7, 1998
Mesothelial cells: the panacea for ex vivo gene therapy?F Paillard
Human Gene Therapy|February 7, 1998
The first physiologically regulated transgene for gene therapy: erythropoietinF Paillard
Human Gene Therapy|April 3, 1998
Growth factors gene delivery to enhance graftingF Paillard
Human Gene Therapy|September 25, 1999
CpG: the double-edged swordF Paillard
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Human Gene Therapy|November 14, 1997
Naked DNA gene delivery to the liverF Paillard
Human Gene Therapy|June 13, 1998
Epstein-Barr virus vectors for the treatment of Epstein-Barr virus-associated cancersF Paillard
Human Gene Therapy|April 29, 1998
Simian virus 40 as a vector for gene transfer to hematopoietic cellsF Paillard
Human Gene Therapy|December 31, 1997
Promoter attenuation in gene therapy: causes and remediesF Paillard
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 6, 2003
[Nutritional counseling for coronary and hypertensive patients]F Paillard
Human Gene Therapy|February 4, 1998
Tumor-specific transgene expression: an application for hepatocarcinoma gene therapyF Paillard
Human Gene Therapy|February 7, 1998
Mesothelial cells: the panacea for ex vivo gene therapy?F Paillard
Human Gene Therapy|February 7, 1998
The first physiologically regulated transgene for gene therapy: erythropoietinF Paillard
Human Gene Therapy|April 3, 1998
Growth factors gene delivery to enhance graftingF Paillard
Human Gene Therapy|September 25, 1999
CpG: the double-edged swordF Paillard
Pageof 12